What is SeaStar Medical Holding Corporation?
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.97M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 210,300 shares $9k |
| 3-6months | 0 | 1750 shares $2k |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 218,700 shares $6k |